Russell Frank Company’s Intersect ENT, Inc XENT Stock Holding History

Russell Frank Company’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$643K	Buy	+33,859	New	+$613K	﹤0.01%	2365
2015 Q4	–	Sell	-83,085	Closed	-$1.94M	–	3063
2015 Q3	$1.94M	Buy	83,085 +8,369	+11%	+$231K	﹤0.01%	1852
2015 Q2	$2.14M	Buy	74,716 +28,885	+63%	+$757K	﹤0.01%	1927
2015 Q1	$1.18M	Buy	+45,831	New	+$1.05M	﹤0.01%	2052

Other funds holding XENT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

KIA

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Russell Frank Company's XENT Position: Q1 2016 in Review

Russell Frank Company opened a new position in Intersect ENT, Inc (XENT) in Q1 2016: 33,859 shares worth $643K. The stake represents ﹤0.01% of the portfolio and ranks #2365 among its holdings. This is a return to the name: Russell Frank Company previously reported a position in XENT as recently as Q3 2015.

Russell Frank Company first reported a position in XENT in Q1 2015 and has held it in 4 quarters since. The position peaked at $2.14M in Q2 2015. 110 funds tracked by Wall St. Rank hold XENT as of Q1 2016.

Russell Frank Company held 33,859 shares of Intersect ENT, Inc worth $643K as of Q1 2016.
Intersect ENT, Inc was a new Russell Frank Company position in Q1 2016.
Intersect ENT, Inc made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2365 holding.
Russell Frank Company first reported a position in Intersect ENT, Inc in Q1 2015 and has held it in 4 quarters since.
Russell Frank Company's Intersect ENT, Inc position peaked at $2.14M in Q2 2015.
110 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.